Free Trial

Bristol-Myers Squibb (BMY) SEC Filings & 10K Form

Bristol-Myers Squibb logo
$56.35 -0.03 (-0.05%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Bristol-Myers Squibb SEC Filings

DateFilerForm TypeView
01/13/2025
9:20 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
5:31 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:25 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:27 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:28 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:30 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:16 PM
Bristol-Myers Squibb (Filer)
Form S-3ASR
11/05/2024
4:48 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:50 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:53 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:41 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:42 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:20 AM
Bristol-Myers Squibb (Subject)
Holzer Phil M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
6:52 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
3:20 PM
Bristol-Myers Squibb (Filed by)
Prime Medicine, Inc. (Subject)
Form SC 13G
10/03/2024
5:33 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:40 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:43 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:45 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:47 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:38 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:01 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
7:12 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
7:08 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 3/A
07/26/2024
11:04 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
6:46 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
4:34 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:23 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:25 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:27 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:29 PM
Bristol-Myers Squibb (Issuer)
McMullen Michael R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2024
4:20 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:22 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:20 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
3:23 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/25/2024
3:24 PM
Bristol-Myers Squibb (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/18/2024
3:23 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:53 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:45 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
11:38 AM
Bristol-Myers Squibb (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
AAPL: Double Your Returns in 24 Hours? (Ad)

Trader Chris Pulver is diving deep into the inner workings of Wall Street... To reveal a trading method he’s kept under wraps for years. You see… Thanks to “liquidity levels” which show us Wall Street’s biggest undercover buy orders in real time… This method has shown the ability to DOUBLE our returns…

You can see them—along with the finer details of how his strategy works—on this page right here.
04/25/2024
6:47 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2024
7:16 AM
Bristol-Myers Squibb (Filer)
Form DEFA14A
04/02/2024
5:37 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:38 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:40 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:41 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:43 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:44 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:45 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
4:16 PM
Bristol-Myers Squibb (Filer)
Form DEF 14A
03/28/2024
4:17 PM
Bristol-Myers Squibb (Filer)
Form DEFA14A
03/28/2024
4:19 PM
Bristol-Myers Squibb (Filer)
Form ARS
03/18/2024
4:21 PM
Bristol-Myers Squibb (Filer)
Form PRE 14A
03/18/2024
4:30 PM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
7:56 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
8:54 PM
Bristol-Myers Squibb (Issuer)
Lenkowsky Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:43 PM
Bristol-Myers Squibb (Issuer)
LEUNG SANDRA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:21 PM
Bristol-Myers Squibb (Issuer)
Plenge Robert M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
8:11 PM
Bristol-Myers Squibb (Issuer)
Poole Ahn Amanda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:40 PM
Bristol-Myers Squibb (Issuer)
Hirawat Samit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:31 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:58 PM
BOERNER CHRISTOPHER S. (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:00 PM
Bristol-Myers Squibb (Issuer)
Gallman Cari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:01 PM
Bristol-Myers Squibb (Issuer)
Hoch Lynelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:46 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:50 PM
Bristol-Myers Squibb (Issuer)
Shanahan Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:42 PM
Bristol-Myers Squibb (Issuer)
Caforio Giovanni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:43 PM
Bristol-Myers Squibb (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
4:45 PM
Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:52 PM
Bristol-Myers Squibb (Issuer)
Hickey Benjamin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
5:03 PM
Bristol-Myers Squibb (Issuer)
Holzer Phil M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/23/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/16/2024
3:34 PM
Bristol-Myers Squibb (Filer)
Form 424B5
02/16/2024
10:36 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/14/2024
8:07 PM
Bristol-Myers Squibb (Subject)
Form FWP
02/13/2024
10:54 AM
Bristol-Myers Squibb (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2024
7:00 AM
Bristol-Myers Squibb (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/12/2024
6:34 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T/A
02/05/2024
6:29 PM
Bristol-Myers Squibb (Issuer)
Vousden Karen H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:31 PM
Bristol-Myers Squibb (Issuer)
Storch Gerald L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:33 PM
Bristol-Myers Squibb (Issuer)
YALE PHYLLIS R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:10 PM
Bristol-Myers Squibb (Issuer)
Meyers Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:13 PM
Arduini Peter J (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:15 PM
Bhatt Deepak (Reporting)
Bristol-Myers Squibb (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:17 PM
Bristol-Myers Squibb (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:21 PM
Bristol-Myers Squibb (Issuer)
Hidalgo Medina Manuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:24 PM
Bristol-Myers Squibb (Issuer)
Price Paula A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:26 PM
Bristol-Myers Squibb (Issuer)
Rice Derica W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:27 PM
Bristol-Myers Squibb (Issuer)
Samuels Theodore R. II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
6:46 AM
Bristol-Myers Squibb (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Ignore every stock… (Ad)

Stocks have been on a tear in 2024… And there’s plenty of great opportunities out there. But one expert says you should forget about EVERY stock for a moment and focus on an even bigger opportunity. The current GOLD supercycle You see, stocks are a dime a dozen for the most part… And, fortunately, they go up more than they go down. But every few decades, precious metals have a systematic supercycle that tends to dwarf the potential of just about anything else. The last time things aligned like this on gold it surged 536%

We put together this handy gold guide for you (no cost) so you know what to look for
01/25/2024
7:13 AM
Bristol-Myers Squibb (Filed by)
RayzeBio, Inc. (Subject)
Form SC TO-T
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:BMY) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners